MRl of Prostate Cancer Antigen Expression for Diagnosis and lmmunotherapy

BACKGROUND: Tumor antigen (TA)–targeted monoclonal antibody (mAb) immunotherapy can be effective for the treatment of a broad range of cancer etiologies; however, these approaches have demonstrated variable clinical efficacy for the treatment of patients with prostate cancer (PCa). An obstacle curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jing, Wang, Fang, Wei, Guangquan, Yang, Yong, Liu, Ying, Wei, Mengqi, Huan, Yi, Larson, Andrew C., Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384648/
https://www.ncbi.nlm.nih.gov/pubmed/22761679
http://dx.doi.org/10.1371/journal.pone.0038350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384648/
https://www.ncbi.nlm.nih.gov/pubmed/22761679
http://dx.doi.org/10.1371/journal.pone.0038350

Ejemplares similares